Standard Biotools (LAB) Consolidated Net Income (2010 - 2026)
Standard Biotools (LAB) posted quarterly Consolidated Net Income of $141.7 million for Q1 2026, up 5420.84% year-over-year from $2.6 million in Q1 2025, and up 2532.74% quarter-over-quarter from $5.4 million in Q4 2025.
Standard Biotools (LAB) Consolidated Net Income (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Consolidated Net Income for 17 consecutive years, with $141.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Consolidated Net Income rose 5420.84% year-over-year to $141.7 million; the TTM figure through Mar 2026 stood at $128.3 million (up 468.06% YoY), while the FY2025 annual figure was -$16.1 million, up 66.48% from the prior year.
- Consolidated Net Income advanced to $141.7 million in Q1 2026 per LAB's latest filing, from $5.4 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $153.2 million in Q4 2022 and bottomed at -$76.3 million in Q1 2022.
- Historically, Consolidated Net Income has averaged $260588.2 across 5 years, with a median of -$15.8 million in 2025.
- Annual changes were most pronounced in 2022 — Consolidated Net Income tumbled 305.96% — and 2026, when it soared 5420.84%.
- Standard Biotools' Consolidated Net Income stood at $153.2 million in 2022, then tumbled by 90.78% to $14.1 million in 2023, then tumbled by 148.84% to -$6.9 million in 2024, then jumped by 178.01% to $5.4 million in 2025, then jumped by 2532.74% to $141.7 million in 2026.
- Business Quant data shows LAB's Consolidated Net Income at $141.7 million in Q1 2026, $5.4 million in Q4 2025, and -$3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | -26.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.23 Mn |
| Mar 31, 2026 | 141.69 Mn |
| Dec 31, 2025 | 5.38 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -15.79 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | -6.90 Mn |
| Sep 30, 2024 | -5.02 Mn |
| Jun 30, 2024 | -20.27 Mn |
| Mar 31, 2024 | -32.13 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | -21.05 Mn |
| Jun 30, 2023 | -17.04 Mn |
| Mar 31, 2023 | -16.84 Mn |
| Dec 31, 2022 | 153.20 Mn |
| Sep 30, 2022 | -29.43 Mn |
| Jun 30, 2022 | -63.55 Mn |
| Mar 31, 2022 | -76.29 Mn |
| Sep 30, 2021 | -49.82 Mn |
| Jun 30, 2021 | -35.95 Mn |